<DOC>
	<DOCNO>NCT02103244</DOCNO>
	<brief_summary>An adjusted dosing algorithm dose anticancer drug carboplatin develop , account high BMI , low serum creatinine value maximal calculate renal function . The hypothesis new dose algorithm provide accurate safe dose dose accord old standard care .</brief_summary>
	<brief_title>Validation Adjusted Dosing Algorithm Carboplatin</brief_title>
	<detailed_description>Carboplatin alkylating anticancer drug use treatment various type cancer , include non-small cell lung cancer ( NSCLC ) , small cell lung cancer ( SCLC ) , malignant mesothelioma , ovarian cancer , breast cancer . It mostly give combination chemotherapeutic drug , also give single agent . Since carboplatin highly eliminate kidney , dose need adjust renal dysfunction . Furthermore , clear correlation area concentration-time curve ( AUC ) carboplatin haematological toxicity response rate , carboplatin dose per target AUC . For , standard pharmacokinetic formula [ dose = clearance carboplatin x target AUC ] use . clearance typically calculate use cockcroft gault ( C-G ) formula . In patient high weight , low serum creatinine value C-G-formula may overestimate renal function , result potential overdose carboplatin . new developed dose algorithm study adjusts high BMI low serum creatinine value , order provide safe dose carboplatin</detailed_description>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>histologically cytologically proven advanced NSCLC , SCLC ovarian cancer treat carboplatin target AUC 4 , 5 6 age 18 year old WHO performance status 0 2 adequate bone marrow liver function define haemoglobin ≥ 6.0 mmol/L white blood cell count ≥ 3.0 * 109/L absolute neutrophil count ( ANC ) ≥ 1.5 * 109/L platelet ≥ 100/L bilirubin ≤ 1.5 time ULN ALAT ASAT ≤ 2.5 time ULN ( case liver metastases ≤ 5.0 time ULN ) . estimate life expectancy least 12 week Treatment carboplatin target AUC &lt; 4 active clinically serious infection history kidney allograft pregnant patient suitable followup pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>safety</keyword>
</DOC>